Summit Therapeutics, Inc. (SMMT)
14.28
+0.16
(+1.17%)
USD |
NASDAQ |
Jun 09, 16:00
13.39
-0.88
(-6.20%)
After-Hours: 17:53
Summit Therapeutics EPS Diluted (TTM) : -1.604 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Revolution Medicines, Inc. | -7.073 |
| Denali Therapeutics, Inc. | -2.881 |
| NovelStem International Corp. | 0.0529 |
| Brainstorm Cell Therapeutics, Inc. | -0.9415 |
| Kezar Life Sciences, Inc. | -6.176 |